Ep 70: Responsible AI and healthcare, with Dr...

Agentic AI systems are causing a huge buzz right now. These are AI systems that actively make changes in the world as opposed to merely giving information. In healthcare, could agentic AI systems help address the huge problem of preventable disease ? This is an economic drain tha ...  Show more

Video calls to your doctor from your home, is old news and very 2021. But what if you could have a consultation with your doctor from home, which involved YOU performing physical exams yourself, AND as accurately as with an in-person visit?This is what new AI-guided tools claim t ...  Show more

Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ...  Show more

It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a ...  Show more

According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop ...  Show more

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more